Keystone Bio
PrivateLast Round
Debt
Mar 11, 2022
Total Funding Raised
$5M
Company Overview
Keystone Bio is a biotherapeutics company that develops diagnostics and therapeutics for inflammation-driven diseases such as Alzheimer's and heart disease by targeting the oral pathogen Porphyromonas gingivalis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keystone Bio Comparables
Compare Keystone Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lighthouse Pharmaceuticals | 82% | |
| Denteric | 78% | |
| ProMIS Neurosciences Inc. | 64% |
Keystone Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 11, 2022 | ||||
| Series A | Apr 29, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2022
Completed a debt financing round.
- Apr 29, 2019
$5M round completed.
Keystone Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Keystone Bio's valuation, stock price, and market status.
Is Keystone Bio a public or private company?
Keystone Bio is a private company.
What is the current stock price of Keystone Bio?
Keystone Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Keystone Bio worth (valuation)?
Valuation information for Keystone Bio is not publicly available.
Can I buy Keystone Bio stock?
Keystone Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Keystone Bio's last funding round?
Funding round information for Keystone Bio is not publicly available.
Who are the main investors in Keystone Bio?
Investor information for Keystone Bio is not publicly disclosed.
Will Keystone Bio IPO soon?
No public IPO plans have been announced for Keystone Bio.
How can I track Keystone Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Keystone Bio's secondary market activity and sign up for updates.